Avenue Therapeutics ATXI Stock
$0.35
17.781664%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$1.15M
LOW - HIGH [24H]
$0.30
-
$0.35
VOLUME [24H]
$2.59K
P/E Ratio
0
Earnings per share
-$0.52
ISIN
US05360L4032
Avenue Therapeutics Price Chart
Avenue Therapeutics ATXI Financial and Trading Overview
| Avenue Therapeutics stock price | 0.35 USD |
| Previous Close | 0.3 USD |
| Open | 0.3 USD |
| Bid | 0.25 USD x 682500 |
| Ask | 0.39 USD x 759900 |
| Day's Range | 0.3 - 0.3 USD |
| 52 Week Range | 0.15 - 0.97 USD |
| Volume | 370 USD |
| Avg. Volume | 4.89K USD |
| Market Cap | 922.59K USD |
| Beta (5Y Monthly) | -0.083 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.52 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ATXI Valuation Measures
| Enterprise Value | -1494409 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.08917197 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.6571154 |
| Price/Book (mrq) | 0.7692308 |
| Enterprise Value/Revenue | -1.064 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Avenue Therapeutics Stock Price History
| Beta (5Y Monthly) | -0.083 |
| 52-Week Change | 7.69% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 0.97 USD |
| 52 Week Low | 0.15 USD |
| 50-Day Moving Average | 0.42 USD |
| 200-Day Moving Average | 0.54 USD |
ATXI Share Statistics
| Avg. Volume (3 month) | 4.89K USD |
| Avg. Daily Volume (10-Days) | 1.85K USD |
| Shares Outstanding | 3.29M |
| Float | 2.85M |
| Short Ratio | 0.65 |
| % Held by Insiders | 20.64% |
| % Held by Institutions | 7.01% |
| Shares Short | 59.7K |
| Short % of Float | 2.82% |
| Short % of Shares Outstanding | 2.82% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:75 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | -124.78% |
| Operating Margin (ttm) | -149.21% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -43.19% |
| Return on Equity (ttm) | -101.076% |
Income Statement
| Revenue (ttm) | 1.4M USD |
| Revenue Per Share (ttm) | 0.44 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 1.4M USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -1752000 USD |
| Diluted EPS (ttm) | -0.52 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.42M USD |
| Total Cash Per Share (mrq) | 0.73 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 1.943 |
| Book Value Per Share (mrq) | 0.364 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1085000 USD |
| Levered Free Cash Flow (ttm) | -719375 USD |
Profile of Avenue Therapeutics
| Country | United States |
| State | FL |
| City | Bay Harbor Islands |
| Address | 1111 Kane Concourse |
| ZIP | 33154 |
| Phone | 781 652 4500 |
| Website | https://avenuetx.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1 |
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. The company product candidates include ATX-04, a small molecule therapy for the treatment of Pompe disease; and intravenous tramadol, a schedule IV opioid to treat post-operative acute pain. The company was incorporated in 2015 and is headquartered in Bay Harbor Islands, Florida.
Q&A For Avenue Therapeutics Stock
What is a current ATXI stock price?
Avenue Therapeutics ATXI stock price today per share is 0.35 USD.
How to purchase Avenue Therapeutics stock?
You can buy ATXI shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Avenue Therapeutics?
The stock symbol or ticker of Avenue Therapeutics is ATXI.
Which industry does the Avenue Therapeutics company belong to?
The Avenue Therapeutics industry is Biotechnology.
How many shares does Avenue Therapeutics have in circulation?
The max supply of Avenue Therapeutics shares is 3.29M.
What is Avenue Therapeutics Price to Earnings Ratio (PE Ratio)?
Avenue Therapeutics PE Ratio is now.
What was Avenue Therapeutics earnings per share over the trailing 12 months (TTM)?
Avenue Therapeutics EPS is -0.52 USD over the trailing 12 months.
Which sector does the Avenue Therapeutics company belong to?
The Avenue Therapeutics sector is Healthcare.
Avenue Therapeutics ATXI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Capital Market Composite RCMP | 148.96 USD — |
-1.84
|
— — | 148.23 USD — | 151.02 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}